Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand
0 sources
Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand
Summary
Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand is a doctoral thesis[1].
Key Facts
- Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand authored Evaluating the impact of generic substitution in New Zealand — author (P50): Charon Lessing[2].
- Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand's instance of is recorded as Evaluating the impact of generic substitution in New Zealand — instance of (P31): doctoral thesis[3].
- Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand's publisher is recorded as Evaluating the impact of generic substitution in New Zealand — publisher (P123): ResearchSpace@Auckland[4].
- Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand's copyright license is recorded as Evaluating the impact of generic substitution in New Zealand — copyright license (P275): Creative Commons Attribution-NonCommercial-ShareAlike 3.0 New Zealand[5].
- Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand's country of origin is recorded as Evaluating the impact of generic substitution in New Zealand — country of origin (P495): New Zealand[6].
- Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand's publication date is recorded as +2015-00-00T00:00:00Z[7].
- Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand's main subject is recorded as Evaluating the impact of generic substitution in New Zealand — main subject (P921): health sciences[8].
- Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand's work available at URL is recorded as https://researchspace.auckland.ac.nz/handle/2292/27558[9].
- Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand's Handle ID is recorded as 2292/27558[10].
- Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand's title is recorded as Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand[11].
- Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand's copyright holder is recorded as Evaluating the impact of generic substitution in New Zealand — copyright holder (P3931): Charon Lessing[12].
- Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand's thesis submitted to is recorded as Evaluating the impact of generic substitution in New Zealand — thesis submitted to (P4101): University of Auckland[13].
- Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand's on focus list of Wikimedia project is recorded as Evaluating the impact of generic substitution in New Zealand — on focus list of Wikimedia project (P5008): NZThesisProject[14].
- Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand's copyright status is recorded as Evaluating the impact of generic substitution in New Zealand — copyright status (P6216): copyrighted[15].
- Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand's online access status is recorded as Evaluating the impact of generic substitution in New Zealand — online access status (P6954): open access[16].
- Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand's thesis committee member is recorded as Evaluating the impact of generic substitution in New Zealand — thesis committee member (P9161): Toni Ashton[17].
- Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand's thesis committee member is recorded as Evaluating the impact of generic substitution in New Zealand — thesis committee member (P9161): Peter Davis[18].
Body
Designation and Status
Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand's instance of is recorded as Evaluating the impact of generic substitution in New Zealand — instance of (P31): doctoral thesis[3].